Suppr超能文献

在一家专业门诊心力衰竭中心,循环NT-proBNP水平对患者进行分层以确定转诊和优先治疗的实用性及预测价值。

Usefulness and predictive value of circulating NT-proBNP levels to stratify patients for referral and priority treatment in a specialized outpatient heart failure center.

作者信息

Amir Offer, Paz Hagar, Ammar Ronny, Yaniv Nisan, Schliamser Jorge E, Lewis Basil S

机构信息

Heart Failure Center, Department of Cardiovascular Medicine, Lady Davis Carmel and Lin Medical Centers, Haifa, Israel.

出版信息

Isr Med Assoc J. 2008 Feb;10(2):109-12.

Abstract

BACKGROUND

Serum natriuretic peptide levels are useful diagnostic and prognostic markers in patients with acute decompensated heart failure, but have been little used to stratify urgency of treatment in the outpatient situation.

OBJECTIVES

To examine the use of natriuretic peptide to guide priority of patient referral to a heart failure center.

METHODS

We analyzed data from 70 consecutive patients with chronic heart failure (NYHA class 2-4) referred for first evaluation in a specialized outpatient heart failure center. Serum NT-proBNP was measured at the initial patient visit. We examined correlates and predictive value of mid- and upper tertile NT-proBNP for mortality in comparison with other known prognostic indicators using univariate and multivariate logistic regression analysis.

RESULTS

Mortality at 6 months was 26.0% in patients with upper tertile (> 1958 pg/ml) NT-proBNP, 8.7% in the middle tertile group and 0% in the lowest tertile (P=0.017). Patients with upper tertile serum NT-proBNP levels (group 3) had lower left ventricular ejection fraction, were more often in atrial fibrillation (P=0.04) and more often had renal failure (P=0.03). Age-adjusted logistic regression analysis identified upper tertile serum NT-proBNP level as the strongest independent predictor of 6 month mortality with a sixfold risk of early death (adjusted odds ratio 6.08, 95% confidence interval 1.58-47.13, P=0.04). NT-proBNP was a more powerful predictor of prognosis than ejection fraction and other traditional outcome markers.

CONCLUSIONS

In heart failure patients referred to an outpatient specialized heart failure center, an upper tertile NT-proBNP level identified patients at high risk for mortality. A single high > 550 pg/ml NT-proBNP measurement appears to be useful for selecting patients for care in a heart failure center, and a level > 2000 pg/ml for assigning patients to high priority management.

摘要

背景

血清利钠肽水平是急性失代偿性心力衰竭患者有用的诊断和预后标志物,但在门诊情况下很少用于分层治疗的紧迫性。

目的

研究利钠肽用于指导患者转诊至心力衰竭中心的优先顺序。

方法

我们分析了70例连续转诊至专门的门诊心力衰竭中心进行首次评估的慢性心力衰竭(纽约心脏协会心功能分级2 - 4级)患者的数据。在患者初次就诊时测量血清NT - proBNP。我们使用单因素和多因素逻辑回归分析,与其他已知的预后指标相比,检查NT - proBNP中、上三分位数与死亡率的相关性和预测价值。

结果

NT - proBNP上三分位数(> 1958 pg/ml)的患者6个月死亡率为26.0%,中三分位数组为8.7%,最低三分位数组为0%(P = 0.017)。血清NT - proBNP水平处于上三分位数的患者(第3组)左心室射血分数较低,房颤发生率更高(P = 0.04),肾衰竭发生率也更高(P = 0.03)。年龄调整后的逻辑回归分析确定血清NT - proBNP上三分位数水平是6个月死亡率最强的独立预测因子,早期死亡风险增加6倍(调整后的优势比为6.08,95%置信区间为1.58 - 47.13,P = 0.04)。NT - proBNP比射血分数和其他传统结局标志物更能有力地预测预后。

结论

在转诊至门诊专门心力衰竭中心的心力衰竭患者中,NT - proBNP上三分位数水平可识别出高死亡风险患者。单次NT - proBNP测量值> 550 pg/ml似乎有助于选择在心力衰竭中心接受治疗的患者,而> 2000 pg/ml的水平可将患者分配到高优先级管理。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验